Application Security

    Web Application Penetration Testing

    OWASP-aligned web application testing covering authentication, session management, business logic, and API integrations.

    The short answer

    What does a web application penetration test cover?

    A web application penetration test checks the parts of a web app a user or attacker can reach: login and session handling, access control between users and roles, input handling (injection and cross-site scripting), business logic and the APIs behind the pages. For MedTech clinician portals and patient apps, it also checks how patient data is exposed and protected.

    275+ FDA submissions supported, zero cybersecurity rejections.

    • Senior team
    • Fixed-fee
    • Reviewer-ready
    • Re-test included
    • Free 30-min call
    • No obligation
    • Senior expert, not a sales rep
    • Fixed-fee quote in 24 hours
    • NDA available on request
    Trusted by leading MedTech manufacturers since 2022 · See client outcomes and awards
    Christian Espinosa, Founder & CEO

    Reviewed by Christian Espinosa, MBA · Founder & CEO

    Last reviewed

    Fixed-fee engagement

    Web application penetration testing: deliverables, inputs, and exclusions

    Included work is defined in the signed proposal. These scope options are not automatic inclusions in every engagement.

    Fixed-fee deliverables

    • Agreed authentication, sessions, authorization, business logic, data handling, and linked API attack-path checks.
    • A Penetration Test Plan, Test Cases, and Test Report for the agreed attack surface and product versions.
    • Documented findings, reproduction evidence, and remediation recommendations. Clean test cases and agreed retest evidence. Device tests trace to documented threats. They distinguish security impact from manufacturer-supplied patient-harm context.

    Required inputs

    • Application URLs and versions, user roles, test accounts, API documentation, and business workflows in scope.
    • Written authorization, rules of engagement, in-scope targets and versions, test windows, and an escalation contact.
    • Test accounts, environment access, architecture and data-flow information, and known access restrictions. Device work also needs intended use, available threat model, and ISO 14971 hazard context.

    Exclusions and separate work

    • Unlisted targets, production disruption, destructive hardware work, and third-party systems without authorization are excluded. Additional interfaces require agreement.
    • SBOM generation, SAST, threat-model creation, and architecture views are separate unless explicitly bundled. A targeted test is not whole-device coverage.
    • General software verification and validation, clinical performance testing, and full QMS implementation or certification are outside Blue Goat's product cybersecurity scope.
    • The manufacturer retains engineering changes, clinical-risk evaluation, risk acceptance, release approval, and regulatory submission decisions. No regulatory outcome is promised.

    Pricing and scope changes

    A written fixed-fee quote after scoping. The proposal names deliverables, versions, assumptions, required inputs, exclusions, and agreed dates. Additional work requires a separately agreed scope change. Missing inputs, access restrictions, manufacturer fixes, and review feedback can affect delivery.

    What's included

    Reviewer-ready deliverables in one engagement

    Every engagement ships with documented artifacts, traceable, complete, and aligned with current guidance.

    • OWASP Top 10 and ASVS coverage
    • Authentication and session testing
    • Business-logic abuse cases
    • Linked API and mobile coverage
    MedTech segments

    Web Application Penetration Testing for these segments

    See how this service applies to your specific MedTech segment.

    FAQ

    Web Application Penetration Testing FAQs

    Cybersecurity alerts and guides

    Goat's Weekly alerts

    Medical device advisories and safety communications, with links to original sources. An alert is a reason to assess applicability, not proof that your device is affected.

    Threat modeling, eSTAR 7.1, and SBOM evidence

    Connect threats to controls and test evidence. Compare the CISA 2026 SBOM fields with the NTIA 2021 baseline the FDA still cites, plus its support fields. Guidance recommendations remain separate from statutory duties.

    Ready to start Web Application Penetration Testing?

    Web app penetration testing that finds what scanners miss.

    OWASP-aligned web application testing covering authentication, session management, business logic, and API integrations.